profit from every $100 of sales.

Keurig Dr Pepper
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
You pay $23.79 for every $1 of profit it makes in a year.
of earnings would pay off all its debt.
Money in, money out
What Keurig Dr Pepper sold, what it kept, and what it did with the cash.
Sales went from $14.1 billion in 2022 to $16.6 billion in 2025, with $2.08 billion of profit last year.
Keurig Dr Pepper handed back 85% of the cash it generated last year.
Keurig Dr Pepper vs. similar companies
Keurig Dr Pepper grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
Keurig Dr Pepper | 23.8× · Fair price | ||
Coca-Cola | 32.6× · Expensive | ||
PepsiCo | 24.1× · Fair price | ||
Monster Beverage | 47.7× · Expensive | ||
Nongfu Spring | 27.3× · Fair price |
AI analysis
An AI analyst reads Keurig Dr Pepper's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 11,618 | 12,683 | 14,057 | 14,814 | 15,351 | 16,603 | |
| 6,486 | 6,977 | 7,323 | 8,080 | 8,529 | 8,999 | |
| 2,480 | 2,894 | 2,783 | 3,194 | 3,309 | 3,653 | |
| 2,899 | 3,905 | 3,121 | 3,973 | 3,382 | 4,194 | |
| 1,325 | 2,146 | 1,436 | 2,181 | 1,441 | 2,079 | |
| 0.93 | 1.50 | 1.01 | 1.55 | 1.05 | 1.53 | |
| 55.8% | 55.0% | 52.1% | 54.5% | 55.6% | 54.2% | |
| 21.3% | 22.8% | 19.8% | 21.6% | 21.6% | 22.0% | |
| 11.4% | 16.9% | 10.2% | 14.7% | 9.4% | 12.5% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 49,779 | 50,598 | 51,837 | 52,130 | 53,430 | 55,459 |
| Cash | 240 | 567 | 535 | 267 | 510 | 1,026 |
| Total debt | 13,488 | 11,882 | 13,583 | 14,824 | 15,554 | 16,141 |
| Total liabilities | 25,949 | 25,626 | 26,712 | 26,454 | 29,187 | 29,943 |
| 23,829 | 24,972 | 25,126 | 25,676 | 24,243 | 25,516 | |
| 1,422 | 1,428 | 1,429 | 1,408 | 1,368 | 1,363 | |
| 5.0% | 7.1% | 4.9% | 6.3% | 5.3% | 6.5% | |
| 5.6% | 8.6% | 5.7% | 8.5% | 5.9% | 8.1% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 2,456 | 2,874 | 2,837 | 1,329 | 2,219 | 1,991 | |
| 461 | 423 | 379 | 481 | 622 | 503 | |
| 1,995 | 2,451 | 2,458 | 848 | 1,597 | 1,488 | |
| Dividends paid | 846 | 955 | 1,080 | 1,142 | 1,194 | 1,250 |
| 0 | 0 | 379 | 706 | 1,110 | 9 | |
| 85 | 88 | 52 | 116 | 98 | 97 |
Valuation
- 23.8×
- 16.0×
- 2.27
- 1.9×
- 3.0×
- 33.2×
- 15.4×
- 3.0%
- 4.2%
- 3.1%
Profitability
- 54.2%
- 22.0%
- 12.5%
- 23.9%
- 6.7%
- 5.9%
- 7.2%
- 2.5%
- 5.7%
- –
Growth
- +7.4%
- +10.5%
- −9.1%
- +8.9%
- −1.6%
Financial health
- 3.6×
- 0.63
- 35.1%
- 4.6×
- 0.64
- 2.12
- 0.23
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
What analysts expect
- Average price target
- $32.33
- Range
- $28.00 – $38.00
- 4 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 23, 2026 | 0.39 | 0.37 | +4.7% |
| Feb 24, 2026 | 0.60 | 0.59 | +1.9% |
| Oct 27, 2025 | 0.54 | 0.54 | +0.6% |
| Jul 24, 2025 | 0.49 | 0.49 | +1.0% |
| Apr 24, 2025 | 0.42 | 0.38 | +9.8% |
| Feb 25, 2025 | 0.58 | 0.57 | +1.6% |
| Oct 24, 2024 | 0.51 | 0.51 | +0.0% |
| Jul 25, 2024 | 0.45 | 0.45 | +0.0% |
Paid per share, each year
$1.92 in 2015 → $0.92 in 2025
How safe it looks
60.1% of its profit
Room to growStretchedMore than it earns: 84.0%
News
Keurig Dr Pepper prices 57.97M common share offering at $34.50Seeking Alpha · Nov 13, 2026Why Did AAPL, KO, KDP Stocks Hit 52-Week Highs Today?Yahoo Finance · Oct 23, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Keurig Dr Pepper
Is Keurig Dr Pepper a good stock to buy?
A business with weak numbers at a fair price. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Keurig Dr Pepper AI analysis
What does Keurig Dr Pepper do?
Keurig Dr Pepper Inc. owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. The company operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. It is in Beverages - Non-Alcoholic, based in Frisco, TX, United States, with 30,600 employees.
Does Keurig Dr Pepper pay a dividend?
Yes. At today's price the dividend is 3.1% a year, about 60% of its yearly profit. In 2025 it paid out $1.25 billion in dividends.
Is Keurig Dr Pepper stock halal?
Questionable. Keurig Dr Pepper sits in a grey zone: its debt is 33% of its market value, between 30% and 33%. How we check
How has Keurig Dr Pepper stock done over the past year?
Up 34.6% over the past twelve months, to $36.34. It traded between $25.31 and $38.25 and is 5.0% below its high.
Who are Keurig Dr Pepper's competitors?
The largest listed companies in the same industry are Coca-Cola, PepsiCo, Monster Beverage and Nongfu Spring. The peers table on this page compares their profit, growth and price with Keurig Dr Pepper's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.



